abstract |
Disclosed herein are novel antiviral compounds and pharmaceutical compositions comprising one or more antiviral compounds, and methods of synthesizing them. Also disclosed herein are methods of ameliorating and/or treating Paramyxovirus infection with one or more small molecule compounds. Examples of paramyxovirus infections include those caused by human respiratory syncytial virus (RSV). |